Health Economic Models

Authors

Laurence Djatche, Thomas Jefferson UniversityFollow
Stefan Varga, Thomas Jefferson UniversityFollow
Robert D. Lieberthal, University of Tennessee, KnoxvilleFollow

Document Type

Data

Publication Date

2018

Abstract

These health economic models calculate the impact of aspirin adherence on healthcare costs and quality adjusted life years in patients with a prior cardiovascular event from a payer perspective. The “no diabetes” model is for patients with a history of cardiovascular disease who do not have diabetes as a comorbid condition. The “diabetes” model is for patients with a history of cardiovascular disease who have type II diabetes as a comorbid condition. These .trex files are designed to be loaded and run in TreeAge software Pro Core 2016 health economic modeling software.

Comments

Data associated with the following article: https://link.springer.com/article/10.1007%2Fs41669-018-0075-2

Laurence M. Djatche, Stefan Varga, and Robert D. Lieberthal. "Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events." PharmacoEconomics 2018

Recommended Citation

Djatche, Laurence; Varga, Stefan; and Lieberthal, Robert D., "Health Economic Models" (2018). Public Health Publications and Other Works.
https://trace.tennessee.edu/utk_publichealth/4